In addition to MONA, which combination of medications is commonly used in the management of myocardial infarction?

In addition to MONA, which combination of medications is commonly used in the management of myocardial infarction?

• A. Beta Blockers, ACE inhibitors, Statins, Heparin
• B. Calcium channel blockers, Diuretics, Nitrates, Antiplatelets
• C. Antibiotics, Antivirals, Antifungals, Steroids
• D. Pain relievers, Sedatives, Antipyretics, Anticoagulants

Answer: (A)

After stabilization with MONA, the aim is to support heart function, prevent further thrombosis, and stabilize the plaque. Beta blockers are added because lowering heart rate and contractility reduces myocardial oxygen demand and helps prevent recurrent ischemia and arrhythmias. ACE inhibitors are important early if there’s LV dysfunction or signs of heart failure; they limit adverse remodeling and improve survival. Starting statins early helps stabilize atherosclerotic plaques and provides lipid-lowering and anti-inflammatory benefits. Heparin is used to prevent propagation of the intracoronary thrombus and reduce the risk of reinfarction during the acute phase. Together, these address hemodynamic stress, remodeling, thrombosis, and inflammation, complementing MONA. Other options don’t fit as well: calcium channel blockers and diuretics aren’t routinely shown to improve mortality in the acute MI setting, and while antimicrobials or steroids aren’t indicated for MI, and generic pain relievers or sedatives don’t improve outcomes, the combination of beta blockers, ACE inhibitors, statins, and heparin best aligns with improving survival and long-term management after an MI.

After stabilization with MONA, the aim is to support heart function, prevent further thrombosis, and stabilize the plaque. Beta blockers are added because lowering heart rate and contractility reduces myocardial oxygen demand and helps prevent recurrent ischemia and arrhythmias. ACE inhibitors are important early if there’s LV dysfunction or signs of heart failure; they limit adverse remodeling and improve survival. Starting statins early helps stabilize atherosclerotic plaques and provides lipid-lowering and anti-inflammatory benefits. Heparin is used to prevent propagation of the intracoronary thrombus and reduce the risk of reinfarction during the acute phase. Together, these address hemodynamic stress, remodeling, thrombosis, and inflammation, complementing MONA.

Other options don’t fit as well: calcium channel blockers and diuretics aren’t routinely shown to improve mortality in the acute MI setting, and while antimicrobials or steroids aren’t indicated for MI, and generic pain relievers or sedatives don’t improve outcomes, the combination of beta blockers, ACE inhibitors, statins, and heparin best aligns with improving survival and long-term management after an MI.